Skip to content

Research

I have been working at the interface of chemistry and biology and have developed skills ranging from Organic Chemistry, Medicinal Chemistry, Radiochemistry and Molecular Imaging. In Oct 2014, I returned to the ICT as Post-Doc to support the organic synthesis requirements across the Yorkshire Cancer Research Medicines Discovery programme. Precisely, I am participating in the: Development of duocarmycin synthetic derivatives as CYPs activated prodrugs Development of small molecule polysialyltransferase inhibitors as potential anti-metastatic agents Also, I have a leading role in developing chemical imaging tools to probe biological systems. I have been working at the interface of chemistry and biology and have developed skills ranging from Organic Chemistry, Medicinal Chemistry, Radiochemistry and Molecular Imaging. In Oct 2014, I returned to the ICT as Post-Doc to support the organic synthesis requirements across the Yorkshire Cancer Research Medicines Discovery programme. Precisely, I am participating in the: Development of duocarmycin synthetic derivatives as CYPs activated prodrugs Development of small molecule polysialyltransferase inhibitors as potential anti-metastatic agents Also, I have a leading role in developing chemical imaging tools to probe biological systems. Current Projects Team member of the project: Cancer Medicines Discovery, Yorkshire Cancer Research funded: Patterson, L.H. (P.I.), Falconer, R.A.; Pors, K.; Afarinkia, K.; Loadman, P.M.; Shnyder S.D. Current Projects Team member of the project: Cancer Medicines Discovery, Yorkshire Cancer Research funded: Patterson, L.H. (P.I.), Falconer, R.A.; Pors, K.; Afarinkia, K.; Loadman, P.M.; Shnyder S.D.